IS6408A - Nýjar amínóprópýlfosfínsýrur - Google Patents

Nýjar amínóprópýlfosfínsýrur

Info

Publication number: IS6408A
Authority: IS; Iceland
Prior art keywords: new; aminopropylphosphinic acids; acids; new aminopropylphosphinic; aminopropylphosphinic
Prior art date: 1999-12-09

Application number

IS6408A

Other languages

English (en)

Other versions

IS2231B (is

Inventor

Elebring Thomas

Guzzo Peter

Swanson Marianne

Von Unge Sverker

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-09

Filing date

2002-06-06

Publication date

2002-06-06

2000-10-09 Priority claimed from SE0003640A external-priority patent/SE0003640D0/xx

2002-06-06 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-06-06 Publication of IS6408A publication Critical patent/IS6408A/is

2007-04-15 Publication of IS2231B publication Critical patent/IS2231B/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/48—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof
- C07F9/4808—Phosphonous acids R—P(OH)2; Thiophosphonous acids including RHP(=O)(OH); Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
- C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

IS6408A 1999-12-09 2002-06-06 Nýjar amínóprópýlfosfínsýrur IS2231B (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9904508A SE9904508D0 (sv)	1999-12-09	1999-12-09	New compounds
SE0003640A SE0003640D0 (sv)	2000-10-09	2000-10-09	New compounds
PCT/SE2000/002426 WO2001042252A1 (en)	1999-12-09	2000-12-04	New aminopropylphosphinic acids

Publications (2)

Publication Number	Publication Date
IS6408A true IS6408A (is)	2002-06-06
IS2231B IS2231B (is)	2007-04-15

Family

ID=26655259

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6408A IS2231B (is)	1999-12-09	2002-06-06	Nýjar amínóprópýlfosfínsýrur

Country Status (33)

Country	Link
US (5)	US6576626B2 (is)
EP (2)	EP1240172B1 (is)
JP (2)	JP3914435B2 (is)
KR (1)	KR100689144B1 (is)
CN (1)	CN1198832C (is)
AR (1)	AR030541A1 (is)
AT (1)	ATE282043T1 (is)
AU (1)	AU780459B2 (is)
BR (1)	BR0016253A (is)
CA (1)	CA2397583C (is)
CZ (1)	CZ20021983A3 (is)
DE (1)	DE60015796T2 (is)
DK (1)	DK1240172T3 (is)
EE (1)	EE05067B1 (is)
ES (1)	ES2230174T3 (is)
HK (2)	HK1048321B (is)
HU (1)	HUP0300301A3 (is)
IL (2)	IL149840A0 (is)
IS (1)	IS2231B (is)
MX (1)	MXPA02005536A (is)
MY (1)	MY125414A (is)
NO (1)	NO329595B1 (is)
NZ (1)	NZ519376A (is)
PL (1)	PL201789B1 (is)
PT (1)	PT1240172E (is)
RU (1)	RU2260595C2 (is)
SE (1)	SE9904508D0 (is)
SI (1)	SI1240172T1 (is)
SK (1)	SK286904B6 (is)
TW (1)	TWI228510B (is)
UA (1)	UA71649C2 (is)
WO (1)	WO2001042252A1 (is)
ZA (1)	ZA200204127B (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9904508D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
US7319095B2 (en) *	1999-12-09	2008-01-15	Astrazeneca Ab	Use of GABAB receptor agonists
MXPA03006998A (es) *	2001-02-05	2004-10-15	Michael Albert Kamm	Tratamiento de trastornos de motilidad esofagica y enfermedad de reflujo gastroesofagico.
AR033779A1 (es) *	2001-06-08	2004-01-07	Astrazeneca Ab	Compuestos utiles en la enfermedad de reflujo
SE0201940D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination II
SE0201939D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New combination
SE0401653D0 (sv)	2004-06-24	2004-06-24	Astrazeneca Ab	New compounds
SE0402462D0 (sv) *	2004-10-08	2004-10-08	Astrazeneca Ab	New process
US7494985B2 (en)	2004-11-03	2009-02-24	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
WO2006050471A2 (en)	2004-11-03	2006-05-11	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US20060160777A1 (en) *	2004-12-27	2006-07-20	Anders Lehmann	New use of GABAbeta receptor agonists
KR20080091452A (ko)	2005-12-23	2008-10-13	아스트라제네카 아베	위장 장애의 치료를 위한 이미다졸 유도체
KR20080087852A (ko)	2005-12-23	2008-10-01	아스트라제네카 아베	Ｇａｂａ-ｂ 수용체 조절제
US7585996B2 (en)	2006-09-15	2009-09-08	Xenoport, Inc.	Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
JP5520816B2 (ja)	2007-05-04	2014-06-11	アストラゼネカ・アクチエボラーグ	アミンおよびアミンオキシドで開始するアルキルホスフィン酸の合成方法
WO2009014491A1 (en) *	2007-07-25	2009-01-29	Astrazeneca Ab	The use of (3-amino-2-fluoropropyl) phosphinic acid for treatment of nerd
WO2009082348A1 (en) *	2007-12-21	2009-07-02	Astrazeneca Ab	Novel crystalline form c of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
US20110054216A1 (en) *	2007-12-21	2011-03-03	Hassan Abbasi	Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a
EP2235027A4 (en) *	2007-12-21	2011-06-22	Astrazeneca Ab	NEW CRYSTALLINE FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID
WO2009145716A1 (en) *	2008-05-28	2009-12-03	Astrazeneca Ab	New pharmaceutical formulation useful in gerd therapy
JP5619756B2 (ja)	2008-11-05	2014-11-05	クラリアント・ファイナンス・（ビーブイアイ）・リミテッド	アルキルアルコール／アクロレインを使用したジアルキルホスフィン酸、−エステル及び−塩の製造方法及びそれらの使用
DE102008056341A1 (de)	2008-11-07	2010-05-12	Clariant International Limited	Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
ES2525550T3 (es)	2008-11-07	2014-12-26	Clariant Finance (Bvi) Limited	Procedimiento para la preparación de ácidos, ésteres y sales dialquilfosfínicos mediante derivados del ácido acrílico y su uso
ES2446305T3 (es)	2008-11-11	2014-03-07	Clariant Finance (Bvi) Limited	Procedimiento para la preparación de ácidos dialquilfosfínicos, sus sales y ésteres mono-alilfuncionalizados con compuestos alílicos y su uso
DE102008060035A1 (de) *	2008-12-02	2010-06-10	Clariant International Limited	Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060535A1 (de)	2008-12-04	2010-06-10	Clariant International Limited	Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung
DE102008063642A1 (de)	2008-12-18	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung
DE102008063627A1 (de)	2008-12-18	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung
WO2010069545A2 (de)	2008-12-18	2010-06-24	Clariant International Ltd	Verfahren zur herstellung von ethylendialkylphosphinsäuren, -estern und -salzen mittels acetylen und ihre verwendung
DE102008063668A1 (de)	2008-12-18	2010-07-01	Clariant International Limited	Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung
DE102008064003A1 (de)	2008-12-19	2010-06-24	Clariant International Limited	Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en)	2010-03-17	2011-09-22	INSERM (Institut National de la Santé et de la Recherche Médicale)	Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
WO2012009646A1 (en)	2010-07-15	2012-01-19	Xenoport, Inc.	Methods of treating fragile x syndrome, down's syndrome, autism and related disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH449046A (de)	1963-07-09	1967-12-31	Ciba Geigy	Verfahren zur Herstellung neuer Aminosäuren
GB8425872D0 (en)	1984-10-12	1984-11-21	Ciba Geigy Ag	Chemical compounds
AU594424B2 (en)	1986-01-03	1990-03-08	University Of Melbourne, The	Gastro-oesophageal reflux composition
US4740332A (en) *	1986-05-12	1988-04-26	E. R. Squibb & Sons, Inc.	Process for preparing phosphonous acids
GB8820266D0 (en)	1988-08-26	1988-09-28	Smith Kline French Lab	Compounds
GB8911017D0 (en)	1989-05-13	1989-06-28	Ciba Geigy Ag	Substituted aminoalkylphosphinic acids
US5281747A (en)	1989-05-13	1994-01-25	Ciba-Geigy Corporation	Substituted aminoalkylphosphinic acids
US5567840A (en)	1989-05-13	1996-10-22	Ciba-Geigy Corporation	Substituted aminoalkylphosphinic acids
US5006560A (en)	1989-12-20	1991-04-09	Schering Corporation	Use of GABA-B selective agonists as anti-tussive agents
IL98502A (en) *	1990-06-22	1998-04-05	Ciba Geigy Ag	History of Aminoalkene Phosphine Acid, Process for Their Preparation and Pharmaceutical Preparations Containing Them
FR2663934B1 (fr)	1990-06-27	1994-06-03	Adir	Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
GB9125615D0 (en) *	1991-12-02	1992-01-29	Wyeth John & Brother Ltd	Amines
AU662404B2 (en) *	1992-05-08	1995-08-31	Novartis Ag	Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
FR2722192A1 (fr)	1994-07-06	1996-01-12	Adir	Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en)	1994-10-14	1994-11-30	Glaxo Group Ltd	Medicaments
SE9603408D0 (sv)	1996-09-18	1996-09-18	Astra Ab	Medical use
SE9904508D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
SE9904507D0 (sv) *	1999-12-09	1999-12-09	Astra Ab	New compounds
US7319095B2 (en) *	1999-12-09	2008-01-15	Astrazeneca Ab	Use of GABAB receptor agonists

1999
- 1999-12-09 SE SE9904508A patent/SE9904508D0/xx unknown
2000
- 2000-04-12 UA UA2002064507A patent/UA71649C2/uk unknown
- 2000-11-27 TW TW089125135A patent/TWI228510B/zh not_active IP Right Cessation
- 2000-12-04 BR BR0016253-1A patent/BR0016253A/pt not_active IP Right Cessation
- 2000-12-04 SK SK764-2002A patent/SK286904B6/sk not_active IP Right Cessation
- 2000-12-04 DE DE60015796T patent/DE60015796T2/de not_active Expired - Lifetime
- 2000-12-04 PT PT00983634T patent/PT1240172E/pt unknown
- 2000-12-04 DK DK00983634T patent/DK1240172T3/da active
- 2000-12-04 ES ES00983634T patent/ES2230174T3/es not_active Expired - Lifetime
- 2000-12-04 CA CA2397583A patent/CA2397583C/en not_active Expired - Fee Related
- 2000-12-04 AR ARP000106418A patent/AR030541A1/es active IP Right Grant
- 2000-12-04 MX MXPA02005536A patent/MXPA02005536A/es active IP Right Grant
- 2000-12-04 JP JP2001543550A patent/JP3914435B2/ja not_active Expired - Fee Related
- 2000-12-04 US US09/786,219 patent/US6576626B2/en not_active Expired - Fee Related
- 2000-12-04 NZ NZ519376A patent/NZ519376A/en not_active IP Right Cessation
- 2000-12-04 EP EP00983634A patent/EP1240172B1/en not_active Expired - Lifetime
- 2000-12-04 WO PCT/SE2000/002426 patent/WO2001042252A1/en active IP Right Grant
- 2000-12-04 PL PL364795A patent/PL201789B1/pl not_active IP Right Cessation
- 2000-12-04 RU RU2002113909/04A patent/RU2260595C2/ru not_active IP Right Cessation
- 2000-12-04 AU AU20364/01A patent/AU780459B2/en not_active Ceased
- 2000-12-04 EP EP04021533A patent/EP1484333A1/en not_active Withdrawn
- 2000-12-04 SI SI200030561T patent/SI1240172T1/xx unknown
- 2000-12-04 EE EEP200200286A patent/EE05067B1/xx not_active IP Right Cessation
- 2000-12-04 HU HU0300301A patent/HUP0300301A3/hu unknown
- 2000-12-04 CZ CZ20021983A patent/CZ20021983A3/cs unknown
- 2000-12-04 AT AT00983634T patent/ATE282043T1/de active
- 2000-12-04 CN CNB008168989A patent/CN1198832C/zh not_active Expired - Fee Related
- 2000-12-04 IL IL14984000A patent/IL149840A0/xx active IP Right Grant
- 2000-12-04 KR KR1020027007355A patent/KR100689144B1/ko not_active IP Right Cessation
- 2000-12-07 MY MYPI20005746A patent/MY125414A/en unknown
2002
- 2002-05-23 ZA ZA200204127A patent/ZA200204127B/xx unknown
- 2002-06-06 IS IS6408A patent/IS2231B/is unknown
- 2002-06-07 NO NO20022728A patent/NO329595B1/no not_active IP Right Cessation
2003
- 2003-01-17 HK HK03100457.3A patent/HK1048321B/zh not_active IP Right Cessation
- 2003-04-04 US US10/406,838 patent/US6841698B2/en not_active Expired - Fee Related
- 2003-07-29 HK HK03105473A patent/HK1053125A1/xx not_active IP Right Cessation
2004
- 2004-01-01 IL IL149840A patent/IL149840A/en not_active IP Right Cessation
- 2004-12-16 US US11/016,543 patent/US7034176B2/en not_active Expired - Fee Related
2006
- 2006-04-07 US US11/400,021 patent/US7807658B2/en not_active Expired - Fee Related
- 2006-06-27 JP JP2006175983A patent/JP2006306885A/ja active Pending
2007
- 2007-07-12 US US11/776,648 patent/US20080146836A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20020060992A (ko)	2002-07-19
ATE282043T1 (de)	2004-11-15
AR030541A1 (es)	2003-08-27
UA71649C2 (en)	2004-12-15
US20050137414A1 (en)	2005-06-23
NO20022728D0 (no)	2002-06-07
DK1240172T3 (da)	2005-02-14
EP1484333A1 (en)	2004-12-08
JP2006306885A (ja)	2006-11-09
US6841698B2 (en)	2005-01-11
US20020156053A1 (en)	2002-10-24
CA2397583A1 (en)	2001-06-14
MY125414A (en)	2006-07-31
US6576626B2 (en)	2003-06-10
PL201789B1 (pl)	2009-05-29
AU780459B2 (en)	2005-03-24
SI1240172T1 (en)	2005-02-28
US7807658B2 (en)	2010-10-05
JP3914435B2 (ja)	2007-05-16
SE9904508D0 (sv)	1999-12-09
WO2001042252A1 (en)	2001-06-14
BR0016253A (pt)	2002-08-27
HUP0300301A3 (en)	2008-12-29
DE60015796T2 (de)	2005-11-03
SK286904B6 (sk)	2009-07-06
AU2036401A (en)	2001-06-18
JP2003516407A (ja)	2003-05-13
NO329595B1 (no)	2010-11-22
RU2260595C2 (ru)	2005-09-20
IL149840A0 (en)	2002-11-10
HK1048321B (zh)	2005-09-30
SK7642002A3 (en)	2002-12-03
PL364795A1 (en)	2004-12-13
MXPA02005536A (es)	2004-09-10
IS2231B (is)	2007-04-15
CA2397583C (en)	2010-11-09
US7034176B2 (en)	2006-04-25
EE05067B1 (et)	2008-08-15
KR100689144B1 (ko)	2007-03-08
US20030220303A1 (en)	2003-11-27
CN1409716A (zh)	2003-04-09
EE200200286A (et)	2003-08-15
HUP0300301A2 (hu)	2003-06-28
PT1240172E (pt)	2005-02-28
US20080146836A1 (en)	2008-06-19
TWI228510B (en)	2005-03-01
HK1048321A1 (en)	2003-03-28
NO20022728L (no)	2002-08-07
CN1198832C (zh)	2005-04-27
ZA200204127B (en)	2003-08-25
ES2230174T3 (es)	2005-05-01
US20070021393A1 (en)	2007-01-25
EP1240172B1 (en)	2004-11-10
EP1240172A1 (en)	2002-09-18
IL149840A (en)	2006-04-10
NZ519376A (en)	2003-11-28
RU2002113909A (ru)	2004-01-10
CZ20021983A3 (cs)	2002-11-13
DE60015796D1 (de)	2004-12-16
HK1053125A1 (en)	2003-10-10

Publication	Publication Date	Title
PT1240172E (pt)	2005-02-28	Novos acidos aminopropilfosfinicos
EE200000573A (et)	2002-04-15	Asendatud indoolalkaanhapped
DE122007000064I1 (de)	2008-01-03	Erythropoietinkonjugate
DE19983871T1 (de)	2002-01-31	Fönvorrichtung
DE10084676T1 (de)	2003-04-30	Einmallanzettvorrichtung
DE50002834D1 (de)	2003-08-14	Handstempel
ATE357433T1 (de)	2007-04-15	4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de)	2005-07-15	4-pyridinyl-n-acyl-l-phenylalanine
EE200100708A (et)	2003-02-17	Asendatud fenoksüäädikhapped
DK1317426T3 (da)	2006-01-09	Betal-thio-aminosyrer
DE50000805D1 (de)	2003-01-09	Aufsitzspanner
DE50006899D1 (de)	2004-07-29	Antistatikum
DE10085008T1 (de)	2002-10-10	Oberflächenbehandlungsdüse
DE50003660D1 (de)	2003-10-16	Diacylhydrazinderivate
DE50006013D1 (de)	2004-05-13	Anschlagpuffer
DE50003259D1 (de)	2003-09-18	Textilie
DE19983890T1 (de)	2002-03-07	Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de)	2003-05-08	Nahfeldoptische untersuchungsvorrichtung
DE50006759D1 (de)	2004-07-15	Piperidinalkohole
DE60032195D1 (de)	2007-01-18	Vorhanggiesser
ATE269311T1 (de)	2004-07-15	Benzoylpyridazine
DE10082008D2 (de)	2002-12-19	Ausbeulgerät
NO20006322D0 (no)	2000-12-12	Glibrett
ATE440824T1 (de)	2009-09-15	Nitro-sulfobenzamide
DE50003283D1 (de)	2003-09-18	Exzenterspannzwinge